Endo Health to Acquire Drug Maker Paladin Labs for $1.5B

Nov 05, 2013


Endo Health will spend about $1.5 billion to buy the Canadian specialty drug maker Paladin Labs, and both will then be folded into a newly formed Irish holding company. Endo also posted better-than-expected third-quarter results Tuesday and issued strong profit guidance for the year. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments